To find out if addition of lignocaine 1.5mg/kg IV improves intubating condition compared to rocuronium 0.6mg/kg IV at 60s after induction.

Comparative study of intubating conditions between low dose rocuronium (0.6mg/kg) and rocuronium (0.6mg/kg) with lignocaine (1.5mg/kg) in adults at 60s after induction.

Status

Active, not recruiting

Phases

Phase 2Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2020/02/023568

Enrollment

Registered

2020-02-25

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: R198- Other specified symptoms and signsinvolving the digestive system and abdomen

Interventions

Intervention1: To evaluate if addition of 1.5mg/kg lignocaine improves intubating conditions compared to 0.6mg/kg rocuronium in adults at 60s after induction.: 1.5mg/kg IV lignocaine will be given to

Eligibility

Inclusion criteria

Inclusion criteria: Age 18-60years ASA I-II

Exclusion criteria

Exclusion criteria: Difficult airway Patients considered full stomach Neurological disorders BMI >30 When intubation lasts for more than 15s

Design outcomes

Primary

Measure	Time frame
To evaluate if addition of 1.5mg/kg lignocaine improves intubating conditions compared to 0.6mg/kg rocuronium in adults at 60s after induction.Timepoint: February 2020 to August 2020	—

Secondary

Measure	Time frame
To compare the hemodynamic response mean arterial pressure and heart rate between the two groups.Timepoint: February 2020 to August 2020	—

Countries

India

Contacts

Public ContactSneha S

Amrita institue of medical sciences

rekhavarghese@aims.amrita.edu9447325249

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026